K243922 is an FDA 510(k) clearance for the Revogene. This device is classified as a Real Time Nucleic Acid Amplification System (Class II - Special Controls, product code OOI).
Submitted by Meridian Bioscience, Inc. (Cincinnati, US). The FDA issued a Cleared decision on March 20, 2025, 90 days after receiving the submission on December 20, 2024.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 862.2570. The System Is A Clinical Multiplex Instrument Intended To Measure And Sort Multiple Signals Generated My Multiple Probes, Intercalating Dyes, Or Other Ligands In An Assay From A Clinical Sample. Signals May Be Generated By Fluorescence Or Other Phenomena And May Be Measured Using Filters On A Photodiode Or Other Detector. It May Integrate Sample And/or Reagent Handling, Amplification, Dedicated Instrument Control, Data Acquisition Software, Raw Data Storage Mechanisms And Other Essential Hardware Components Along With The Signal Reader Unit. The System Is Used With Specific Assays To Comprise An Assay Test System..